Do you have idiopathic gastroparesis?

If so, consider joining envision GI study, an idiopathic gastroparesis clinical trial researching an
investigational delayed gastric emptying treatment option.

What is the Envision GI study?


The Envision GI study is a clinical research study for people who have been diagnosed with idiopathic gastroparesis. The main purpose of this study is to find out how well the study medication (CIN-102, deudomperidone) improves the symptoms associated with idiopathic gastroparesis.

Who can join the study?

You may be able to join the study if you meet the following requirements:

  • Age 18 or older
  • Confirmed diagnosis of idiopathic gastroparesis
  • Gastrointestinal symptoms within the last 6 months such as:
  • Nausea or vomiting after eating
  • Feeling too full after eating
  • Bloating
  • Throat or stomach pain

Other criteria apply. Talk to your doctor to learn more.

Thank you for your interest in the Envision GI study! Please complete the form below to be contacted by one of our team members.

View the Understanding Gastroparesis presentation from Dr. Patel below.